Marcela-Maria-Fontes
Borges MMF, Malta CEN, Ribeiro RS, Cetira-Filho EL, Moura JFB, Rebouças LM,
Costa FWG, Silva PGB, Mota MRL. Chemotherapy increases the prevalence of
radiotherapy-related trismus in head and neck cancer patients: A systematic
review and meta-analysis. J Clin Exp Dent. 2024;16(4):e503-15.
doi:10.4317/jced.61385
https://doi.org/10.4317/jced.61385
______
References
|
1.
Guan J, Li Q, Zhang Y, Xiao N, Chen M, Zhang Y, et al. A meta-analysis
comparing cisplatin-based to carboplatin-based chemotherapy in moderate to
advanced squamous cell carcinoma of head and neck (SCCHN). Oncotarget.
2016;7:7110-7119. |
|
|
|
|
|
2.
Zackrisson B, Mercke C, Strander H, Wennerberg J, Cavallin-Stahl E. A
systematic overview of radiation therapy effects in head and neck cancer.
Acta Oncologica. 2003;42:443-461. |
|
|
|
|
|
3.
Silva PSLD, Leão VML, Scarpel RD. Characterizing the population with mouth
and orofaringe cancer, attended in the sector of head and neck in a referral
hospital in Salvador City-BA. Revista CEFAC. 2009;11:441-447. |
|
|
|
|
|
4.
Skiba-Tatarska M, Kusa-Podkańska M, Surtel A, Wysokińska-Miszczuk J. The
side-effects of head and neck tumors radiotherapy. Polskie Towarzystwo
Lekarskie. 2016;41:47-49. PMid:27734822 |
|
|
|
|
|
5.
Mostel DD, Bauer RL, Lynch DP, Hwang ST. Oral complications in the treatment
of cancer patients. Oral diseases. 2011;17:550-559. |
|
|
|
|
|
6.
Schutte HW, Heutink F, Wellenstein DJ, Broek GBVD, Hoogen FJA, Marres HAM, et
al. Impact of Time to Diagnosis and Treatment in Head and Neck Cancer: a
systematic review. Otolaryngology-Head And Neck Surgery. 2020;162:446-457. |
|
|
|
|
|
7.
Langendijk JA. New developments in radiotherapy of head and neck cancer:
higher precision with less patient discomfort? Radiotherapy and Oncology.
2007;85:1-6. |
|
|
|
|
|
8.
Sher DJ, Thotakura V, Balboni TA, Norris CMJ, Haddad RI, Posner MR. Treatment
of oral cavity squamous cell carcinoma with adjuvant or definitive
intensity-modulated radiation therapy. International Journal of Radiation
Oncology Biology Physics. 2011;81:e215-e222. |
|
|
|
|
|
9.
Beitler JJ, Zhang Q, Fu KK, Trotti A, Spencer SA, Jones CU. Final Results of
Local-Regional Control and Late Toxicity of RTOG 90-03; A Randomized Trial of
Altered Fractionation Radiation for Locally Advanced Head And Neck Cancer.
International journal of radiation oncology, biology, physics. 2014;89:13-20. |
|
|
|
|
|
10.
Molin Y, Fayette J. Current chemotherapies for recurrent/metastatic head and
neck cancer. Anti-cancer drugs. 2011;22:621-625. |
|
|
|
|
|
11.
Carroll WR, Locher JL, Canon CL, Bohannon IA, Mccolloch NL, Magnuson JS.
Pretreatment swallowing exercises improve swallow function after
chemoradiation. The Laryngoscope. 2008;118:39-43. |
|
|
|
|
|
12.
Dijkstra PU, Huisman PM, Roodenburg JLN. Criteria for trismus in head and
neck oncology. International journal of oral and maxillofacial surgery.
2006;35:337-342. |
|
|
|
|
|
13.
Kraaijenga SAC, Oskam IM, Molen LVD, Hamming-Vrieze O, Hilgers FJM, Brekel
MWMVD. Evaluation of long term (10-years+) dysphagia and trismus in patients
treated with concurrent chemo-radiotherapy for advanced head and neck cancer.
Oral oncology. 2015;51:787-794. |
|
|
|
|
|
14.
Kamstra JL, Jager-Wittenaar H, Dijkstra PU, Huisman PM, Oort RPV, Laan BFAMVD
et al. Oral symptoms and functional outcome related to oral and oropharyngeal
cancer. Supportive Care in Cancer. 2011;19:1327-1333. |
|
|
|
|
|
15.
Scott B, Butterworth C, Lowe D, Rogers SN. Factors associated with restricted
mouth opening and its relationship to health-related quality of life in
patients attending a Maxillofacial Oncology clinic. Oral oncology. 2008;44:430-438. |
|
|
|
|
|
16.
Weber C, Dommerich S, Pau HW, Kramp B. Limited mouth opening after primary
therapy of head and neck cancer. Oral and maxillofacial surgery. 2010;14:169-173. |
|
|
|
|
|
17.
Stubblefield MD, Manfield L, Riedel ER. A preliminary report on the efficacy
of a dynamic jaw opening device (dynasplint trismus system) as part of the
multimodal treatment of trismus in patients with head and neck cancer.
Archives of physical medicine and rehabilitation. 2010;91:1278-1282. |
|
|
|
|
|
18.
Jham BC, Silva ARFD. Oral complications of radiotherapy in the head and neck.
Brazilian journal of otorhinolaryngology. 2006;72:704-708. |
|
|
|
|
|
19.
Watters AL, Cope S, Keller MN, Padilla M, Enciso R. Prevalence of trismus in
patients with head and neck cancer: A systematic review with meta-analysis.
Head & neck. 2019;41:3408-3421. |
|
|
|
|
|
20.
Bonzanini LIL, Soldera EB, Ortigara GB., Schulz RE, Antoniazzi RP, Ardenghi
TM, et al. Clinical and sociodemographic factors that affect the quality of
life of survivors of head and neck cancer. Supportive Care in Cancer.
2020;28:1941-1950. |
|
|
|
|
|
21.
Pauli N, Johnson J, Finizia C, Andrell P. The incidence of trismus and
long-term impact on health-related quality of life in patients with head and
neck cancer. Acta Oncologica. 2013;52:1137-1145. |
|
|
|
|
|
22.
Johnson J, Johansson M, Rydén A, Houltz E, Finizia C. Impact of trismus on
health-related quality of life and mental health. Head & Neck.
2015;37:1672-1679. |
|
|
|
|
|
23.
Humanes B, Camaño S, Lara JM, Sabbisetti V, González-Nicolás MÁ, Bonventre
JV, et al. Cisplatin-induced renal inflammation is ameliorated by cilastatin
nephroprotection. Nephrology Dialysis Transplantation. 2017;32:1645-1655. |
|
|
|
|
|
24.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al.
The PRISMA 2020 statement: an updated guideline for reporting systematic
reviews. 2021;372:n71. |
|
|
|
|
|
25.
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app
for systematic reviews. Systematic reviews. 2016;5:1-10. |
|
|
|
|
|
26.
Schünemann H, Brożek J, Guyatt G, Oxman A. Handbook for grading the quality
of evidence and the strength of recommendations using the GRADE approach.
Updated October. 2013. |
|
|
|
|
|
27.
Cardoso RC, Kamal M, Zaveri J, Chambers MS, Gunn GB, Fuller CD, et al.
Self-Reported Trismus: prevalence, severity and impact on quality of life in
oropharyngeal cancer survivorship: a cross-sectional survey report from a
comprehensive cancer center. Supportive Care in Cancer. 2020;29:1825-1835. |
|
|
|
|
|
28.
Jeremic G, Venkatesan V, Hallock A, Scott D, Hammond A, Read N, et al.
Trismus following treatment of head and neck cancer. Journal of
Otolaryngology--Head & Neck Surgery. 2011;40:323-9. PMid:21777551 |
|
|
|
|
|
29.
Lee LY, Chen SC, Chen WC, Huang BS, Lin CY. Postradiation trismus and its
impact on quality of life in patients with head and neck cancer. Oral
surgery, oral medicine, oral pathology and oral radiology. 2014;119:187-195. |
|
|
|
|
|
30.
Lyons AJ, Crichton S, Pezier T. Trismus following radiotherapy to the head
and neck is likely to have distinct genotype dependent cause. Oral oncology.
2013;49:932-936. |
|
|
|
|
|
31.
Ou X, Zhou X, Shi Q, Xing X, Yang Y, Xu T, et al. Treatment outcomes and late
toxicities of 869 patients with nasopharyngeal carcinoma treated with
definitive intensity modulated radiation therapy: new insight into the value
of total dose of cisplatin and radiation boost. Oncotarget. 2015;6:381-83. |
|
|
|
|
|
32.
Morimoto M, Bijl HP, Schaaf AVD, Xu CJ, Steenbakkers RJ, Chouvalova O, et al.
Development of normal tissue complication probability model for trismus in
head and neck cancer patients treated with radiotherapy: The role of
dosimetric and clinical factors. Anticancer research. 2019;39:6787-6798. |
|
|
|
|
|
33.
Steiner F, Evans J, Marsh R, Rigby P, James S, Sutherland K, et al. Mouth
opening and trismus in patients undergoing curative treatment for head and
neck cancer. International journal of oral and maxillofacial surgery.
2015;44:292-296. |
|
|
|
|
|
34.
Strojan P, Hutcheson KA, Eisbruch A, Beitler JJ, Langendijk JA, Lee AW, et
al. Treatment of late sequelae after radiotherapy for head and neck cancer.
Cancer treatment reviews. 2017;59:79-92. |
|
|
|
|
|
35.
Wang CJ, Huang EY, Hsu HC, Chen HC, Fang FM, Hsiung CY. The degree and
time-course assessment of radiation-induced trismus occurring after
radiotherapy for nasopharyngeal cancer. The Laryngoscope. 2005;115:1458-1460. |
|
|
|
|
|
36.
Rao SD, Saleh ZH, Setton J, Tam M, McBride SM, Riaz N, et al. Dose-volume
factors correlating with trismus following chemoradiation for head and neck
cancer. Acta Oncologica. 2016;55:99-104. |
|
|
|
|
|
37.
Hague C, Beasley W, Garcez K, Lee LW, McPartlin A, McWilliam A, et al.
Prospective evaluation of relationships between radiotherapy dose to
masticatory apparatus and trismus. Acta Oncologica. 2018;57:1038-1042. |
|
|
|
|
|
38.
Bossi P, Bergamini C, Miceli R, Cova A, Orlandi E, Resteghini C, et al.
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients
Treated With Chemotherapy and Radiation Therapy. International Journal Of
Radiation Oncology Biology Physics. 2016;96:959-966. |
|
|
|
|
|
39.
Logan RM, Stringer AM, Bowen JM, Gibson, Stephen TS, Keefe. Serum levels of
NF-κB and pro-inflammatory cytokines following administration of mucotoxic
drugs. Cancer Biology & Therapy. 2008;7:1139-1145. |
|
|
|
|
|
40.
Watters AL, Cope S, Keller MN, Padilla M. Prevalence of trismus in patients
with head and neck cancer: A systematic review with meta-analysis. Head &
neck. 2010;41:3408-3421. |
|
|
|
|
|
41.
Kraaijenga, SAC; Oskam, IM; Molen, LVD; Hamming-Vrieze, O; Hilgers, FJM &
Brekel, MWMVD. Evaluation of long term (10-years+) dysphagia and trismus in
patients treated with concurrent chemo-radiotherapy for advanced head and
neck cancer. Oral oncology. 2015;51,787-794. |
|
|
|
|
|
42.
Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan
MT. A systematic review of trismus induced by cancer therapies in head and
neck cancer patients. Supportive Care in Cancer. 2010;18:1033-1038. |
|
|
|
|
|
43.
Filho ELC, Carvalho FSR, Silva PGB, Barbosa DAF, Pereira KMA, Ribeiro TR, et
al. Preemptive use of oral nonsteroidal anti-inflammatory drugs for the
relief of inflammatory events after surgical removal of lower third molars: A
systematic review with meta-analysis of placebo-controlled randomized
clinical trials. Journal of Cranio-Maxillofacial Surgery. 2020;48:293-307. |
|
|
|
|
|
44.
Ortigara GB, Schulz RE, Soldera EB, Bonzanini LIL, Danesi CC, Antoniazzi RP,
et al. Association between trismus and dysphagia-related quality of life in
survivors of head and neck cancer in Brazil. Oral surgery, oral medicine,
oral pathology and oral radiology. 2019;128:235-242. |
|
|
|
|
|
45.
Crowder SL, Douglas KG, Pepino MY, Sarma KP, Arthur AE. Nutrition impact
symptoms and associated outcomes in post-chemoradiotherapy head and neck
cancer survivors: a systematic review. Journal of Cancer Survivorship.
2018;12:479-494. |
|
|
|
|
|
46.
Astradsson T, Laurell G, Ahlberg A, Nikolaidis P, Johansson H, Ehrsson YT.
Trismus in patients with head and neck cancer and 5-year overall survival.
Acta oto-laryngologica. 2018;138:1123-1127. |
|
|
|
|
|
47.
Retèl VP, Molen LVD, Hilgers FJ, Rasch CR, l'Ortye AA, Steuten LM, Harten
WHV. A cost-effectiveness analysis of a preventive exercise program for
patients with advanced head and neck cancer treated with concomitant
chemo-radiotherapy. BMC cancer. 2011;11:1-9. |
|
|
|
|
|
48.
Kamstra JI, Leeuwen MV, Roodenburg JL, Dijkstra PU. Exercise therapy for
trismus secondary to head and neck cancer: a systematic review. Head &
neck. 2017;39:2352-2362. |
|